Orazio Vittorio

Papers

Total Citations

H-Index

About

Dr. Orazio Vittorio is a pioneering researcher at the intersection of nanotechnology, cancer biology, and biomedical engineering. His work focuses on developing innovative therapeutic strategies for pediatric and adult cancers, particularly targeting copper metabolism and oxidative stress in tumors. Dr. Vittorio’s major contributions include the discovery that copper chelation can selectively induce apoptosis in cancer cells while sparing healthy tissue, leading to the development of novel nanoparticle-based therapies. His research has garnered over 4,000 citations, reflecting its profound impact on the field. Notably, his recent work on motor-free soft robots for cancer detection, surgery, and in situ bioprinting (2025) represents a groundbreaking advance in minimally invasive surgical technologies, integrating robotics with real-time diagnostic and therapeutic capabilities. Dr. Vittorio has also been recognized with prestigious awards, including the Australian Research Council Discovery Early Career Researcher Award (DECRA), and holds multiple patents for his nanomedicine innovations. His interdisciplinary approach continues to shape the future of precision oncology and smart surgical tools.